Navigation Links
Breakthrough In Prostate Cancer Detection And Treatment

In a research conducted in the US, scientists have claimed that a new blood test they have now found could change the way the disease of prostate cancer is diagnosed and// treated.

Researchers hoping that the test will be available to patients in 18 months, have explained that not only is the test more accurate than the standard PSA test, but it might also be able to identify the cancers that have begun to spread.

Researchers had explained that for many years the levels of Protein specific antigen or PSA could be calculated in a test had been considered as the most reliable primary indicator of prostate cancer. But there did exist a problem with the test as many a times it was found that there were some patients with abnormal levels who were cancer-free, while others have cancers but it was missed as the readings were very low. PSA is a protein that is released into the blood by prostate cells.

It was reported that the Johns Hopkins Medical Institutions in Baltimore, Maryland, US, have developed the new test. It was explained that the test now looks for a different protein called early prostate cancer antigen-2, or EPCA-2. The researchers further explained that patients with an EPCA-2 cut-off level of 30 monograms per millilitre (ngml) of blood or higher are thought to be at risk of acquiring prostate cancer.

The researchers had explained that they conducted their study of tests on 330 patients, which even included some who had prostate cancer, and that the came up with the result of the test showing a negative result for 97% of patients who did not have the disease. They also explained that the EPCA-2 levels at or above the cut-off point were found in 90% of men with cancer that was restricted to the prostate, and 98% of those with cancer that had begun its spread away from the gland.

It was explained that on the overall, the test was successful in identifying prostate cancer patients with an accuracy of 94%, in comparison with the old PSA levels of between four and 10 ngml that were detected in only 85% of patients with prostate cancer.
'"/>




Related medicine news :

1. Sperm washing helps couples – Breakthrough in focu
2. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
3. Breakthrough in eye treatment
4. Genetic Breakthrough in Common Eye Problem
5. Breakthrough in cancer therapy
6. Breakthrough in Type II Diabetes
7. Breakthrough In Stem Cell Work
8. A Likely Breakthrough For Prostate Cancer Patients
9. New DNA Breakthrough Can Change Future Of Medicine
10. Breakthrough In New Vaccine For Malaria
11. Medical Breakthrough - Kidney Transplant Recipient Survives Without Drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
(Date:4/28/2017)... ... 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... to and which He does not. Yisrayl says with so many titles and names ... name, but he says with a little Scripture, backed with a lot of research, the ...
(Date:4/28/2017)... ... 28, 2017 , ... Intellitec Solutions announced the publication of ... Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software package. With ... care, Brooke Grove now has the capability to achieve its goal for a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Rob Lowe is a popular actor ... leant his presence to an educational purpose as the host of the “Informed” series. ... cancer. In a recent episode, the series focuses on thyroid cancer. , Although thyroid ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... release financial results for the first quarter 2017 after ... The Company,s management team will host a corresponding conference ... ET. Investors interested in listening to the ... for domestic callers or (703) 326-3030 for international callers, ...
(Date:4/19/2017)... 19, 2017 The Global Effective Microorganisms ... 2022 report has covered and analysed the potential of Global ... market size, shares and growth factors. The report identifies and ... opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, ...
Breaking Medicine Technology: